Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes

Journal of Medical Virology

Volumn 87, Issue 2, 2015, Pages 248-255

  Corrales, Isabel ^a   Giménez, Estela ^a   Solano, Carlos ^a,b   Amat, Paula ^a   de la Cámara, Rafael ^c   Nieto, José ^d   Garcia Noblejas, Ana ^c   Navarro, David ^a,b  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^d HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Allogeneic stem cell transplantation; CMV DNAemia; Cytomegalovirus (CMV); Single nucleotide polymorphisms

Indexed keywords

ANTIVIRUS AGENT; CHEMOKINE RECEPTOR CCR5; INTERLEUKIN 10; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 9; CCL2 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN; IL10 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN; VIRUS DNA;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIVIRAL THERAPY; ARTICLE; ASSOCIATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; FEMALE; GENETIC ASSOCIATION; GRAFT RECIPIENT; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OBSERVATIONAL STUDY; ORGAN DONOR; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ADVERSE EFFECTS; AGED; ALLOTRANSPLANTATION; BLOOD; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTIONS; DONOR; GENETICS; MIDDLE AGED; MULTICENTER STUDY; STEM CELL TRANSPLANTATION; VIREMIA; YOUNG ADULT;

CYTOMEGALOVIRUS;

ADOLESCENT; ADULT; AGED; CHEMOKINE CCL2; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; INCIDENCE; INTERLEUKIN-10; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR5; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TISSUE DONORS; TOLL-LIKE RECEPTOR 9; TRANSPLANT RECIPIENTS; TRANSPLANTATION, HOMOLOGOUS; VIREMIA; YOUNG ADULT;

EID: 84919838991     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24050     Document Type: Article

References (21)

1. Alkhatib G. 2009. The biology of CCR5 and CXCR4. Curr Opin HIV AIDS 4:96-103.
2. Bogunia-Kubik K, Jaskula E, Lange A. 2007. The presence of functional CCR5 and EBV, reactivation after allogeneic haematopoietic stem cell transplantation. Bone Marrow Transpl 40:145-150.
3. Bravo D, Clari MA, Aguilar G, Belda J, Giménez E, Carbonell JA, Henao L, Navarro D. 2014. Looking for biological factors to predict the risk of active cytomegalovirus infection in non-immunosuppressed critically ill patients. J Med Virol 86:827-833.
4. Bravo D, Solano C, Giménez E, Remigia MJ, Corrales I, Amat P, Navarro D. 2014. Effect of the IL28B Rs12979860 C/T polymorphism on the incidence and features of active cytomegalovirus infection in allogeneic stem cell transplant patients. J Med Virol 86:838-844.
5. Clari MÁ, Bravo D, Costa E, Muñoz-Cobo B, Solano C, Remigia MJ, Giménez E, Benmarzouk-Hidalgo OJ, Pérez-Romero P, Navarro D. 2013. Comparison of the new Abbott Real Time CMV assay and the Abbott CMV PCR Kit for the quantitation of plasma cytomegalovirus DNAemia. Diagn Microbiol Infect Dis 75:207-209.
6. Cook CH, Trgovcich J, Zimmerman PD, Zhang Y, Sedmak DD. 2006. Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol 80:9151-9158.
7. Dwinell MB1, Eckmann L, Leopard JD, Varki NM, Kagnoff MF. 1999. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117:359-367.
8. Ge D, Fellay J, Thompson AJ, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, Sulkowski M, McHutchison JG, Goldstein DB. 2009. Genetic variationin IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461:399-401.
9. Lien E, Ingalls RR. 2002. Toll-like receptors. Crit Care Med 30:S1-11.
10. Loeffler J, Steffens M, Arlt EM, Toliat MR, Mezger M, Suk A, Wienker TF, Hebart H, Nürnberg P, Boeckh M, Ljungman P, Trenschel R, Einsele H. 2006. Polymorphisms in the genes encoding chemokine receptor 5, interleukin-10, and monocyte chemoattractant protein 1 contribute to cytomegalovirus reactivation and disease after allogeneic stem cell transplantation. J Clin Microbiol 44:1847-1850.
11. Lui YY, Chik KW, Chiu RW, Ho CY, Lam CW, Lo YM. 2002. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421-427.
12. McDermott DH, Conway SE, Wang T, Ricklefs SM, Agovi MA, Porcella SF, Tran HT, Milford E, Spellman S, Abdi R. 2010. Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation. Blood 115:2311-2318.
13. McDermott DH, Zimmerman PA, Guignard F, Kleeberger CA, Leitman SF, Murphy PH. 1998. CCR5 promoter polymorphism and HIV-1 disease progression. Multicenter AIDS Cohort Study (MACS). Lancet 352:866-870.
14. Mezger M, Steffens M, Semmler C, Arlt EM, Zimmer K, Kristjanson GI, Wienker TF, Toliat MR, Kessler T, Einsele H, Loeffler J. 2008. Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation. Clin Microbiol Infect 14:228-234.
15. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
16. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M. 1996. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382:722-725.
17. Solano C, Navarro D. 2010. Clinical virology of cytomegalovirus infection following hematopoietic transplantation. Future Virol 5:111-124.
18. Thio CL, Astemborski J, Bashirova A, Mosbruger T, Greer S, Witt MD, Goedert JJ, Hilgartner M, Majeske A, O'Brien SJ, Thomas DL, Carrington M. 2007. Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence. J Virol 81:441445.
19. Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D. 2011. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Bone Marrow Transpl 46:1437-1443.
20. Woitas RP, Ahlenstiel G, Iwan A, Rockstroh JK, Brackmann HH, Kupfer B, Matz B, Offergeld R, Sauerbruch T, Spengler U. 2002. Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C. Gastroenterology 122:1721-1728.
21. Yoshimura T, Leonard EJ. 1991. Human monocyte chemoattractant protein-1 (MCP-1). Adv Exp Med Biol 305:47-56.